Windtree Therapeutics, Inc.
WINT
$1.30
$0.075.69%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/26/2025
-
The Fly
3/26/2025
-
PR Newswire
3/24/2025
-
Benzinga
3/24/2025
-
PR Newswire
3/24/2025
-
TipRanks Financial Blog
3/24/2025
-
Seeking Alpha - Healthcare
3/24/2025
-
The Fly
3/24/2025
-
GuruFocus
3/24/2025
-
Globe Newswire
3/21/2025
-
MarketBeat
3/20/2025
-
Benzinga
3/20/2025
-
Globe Newswire
3/4/2025
-
Benzinga
3/4/2025
-
TipRanks Financial Blog
3/4/2025
-
Globe Newswire
2/27/2025
-
The Fly
2/27/2025
-
Globe Newswire
2/21/2025
-
The Fly
2/18/2025
-
SeekingAlpha.com: All News
2/18/2025
-
Seeking Alpha - Healthcare
2/18/2025
-
GuruFocus
2/18/2025
-
The Fly
2/18/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 26, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 14 and 18 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
215 488 9300
Address
2600 Kelly Road
Warrington, PA 18976-3622
Warrington, PA 18976-3622
Country
Year Founded
Business Description
Sector
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is...
more
